All Comments by
- Bradley Hyman on Amyloid-beta dynamics correlate with neurological status in the injured human brain.
- Johan van Beek on Complement C3 deficiency leads to accelerated amyloid beta plaque deposition and neurodegeneration and modulation of the microglia/macrophage phenotype in amyloid precursor protein transgenic mice.
- Boris Schmidt on Chicago: Out of the Blue—A Tau-based Treatment for AD?
- Terrence Town on Why Good Microglia Turn Bad—A Matter of Timing?
- Boris Schmidt on Enhanced clearance of Abeta in brain by sustaining the plasmin proteolysis cascade.
- Baoli He on A TAG1-APP signalling pathway through Fe65 negatively modulates neurogenesis.
- Francisco Gonzalez-Lima on Chicago: Out of the Blue—A Tau-based Treatment for AD?
- Jane Karlsson on Chicago: Out of the Blue—A Tau-based Treatment for AD?
- P.F. Jennings on Chicago: Out of the Blue—A Tau-based Treatment for AD?
- Jeffrey Agar on Protein aggregation and protein instability govern familial amyotrophic lateral sclerosis patient survival.
- Paul Coleman on The role of the cell surface LRP and soluble LRP in blood-brain barrier Abeta clearance in Alzheimer's disease.
- Wolfgang Streit on Why Good Microglia Turn Bad—A Matter of Timing?
- David R. Borchelt on Protein aggregation and protein instability govern familial amyotrophic lateral sclerosis patient survival.
- Steve Barger on A PD Trifecta: Synuclein Gene Expression, Aging, and Inflammation
- Milan Fiala on Macrophages Storm Blood-brain Barrier, Clear Plaques—or Do They?